+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infection Surveillance Solutions - Global Strategic Business Report

  • PDF Icon

    Report

  • 254 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5947953
The global market for Infection Surveillance Solutions was valued at US$852.9 Million in 2024 and is projected to reach US$2.1 Billion by 2030, growing at a CAGR of 16.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Infection Surveillance Solutions Market - Key Trends & Drivers Summarized

What Are Infection Surveillance Solutions and Why Are They Critical?

Infection surveillance solutions are systems and software used by healthcare facilities to monitor and prevent the occurrence and spread of infections within healthcare settings. These systems collect, analyze, and interpret health data to identify potential infection outbreaks and to ensure timely intervention. Such solutions are crucial for maintaining patient safety, managing antimicrobial resistance, and enhancing the overall quality of healthcare services. They track various indicators, including the types of infections, the points of origin within the facility, and the effectiveness of infection control measures. This ongoing surveillance supports hospitals in adhering to regulatory standards and improving patient outcomes.

How Is Technology Enhancing Infection Control?

Advancements in technology have significantly bolstered the capabilities of infection surveillance solutions. Modern systems integrate electronic health records (EHRs), real-time data monitoring, and advanced analytics to provide comprehensive surveillance capabilities. Artificial intelligence (AI) and machine learning (ML) are increasingly being employed to predict infection risks and outbreak patterns, thereby enabling proactive measures. Additionally, mobile platforms enhance the accessibility of surveillance data, facilitating faster response times and improved coordination among healthcare teams. These technological improvements not only increase the efficiency of data management but also enhance the accuracy of infection tracking and the effectiveness of preventive strategies.

What Impact Does Regulatory Compliance Have on the Adoption of These Systems?

Regulatory compliance is a significant driver for the adoption of infection surveillance solutions. In many regions, health authorities require healthcare facilities to implement robust infection control programs to maintain accreditation and receive funding. For instance, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) both provide guidelines and standards for infection surveillance and control. Compliance with these regulations necessitates the adoption of sophisticated surveillance systems capable of providing detailed and accurate data reporting. As regulatory frameworks around the world tighten and focus more on patient safety and quality of care, healthcare providers are increasingly reliant on these solutions to meet their compliance and care standards.

What Drives Growth in the Infection Surveillance Solutions Market?

The growth in the infection surveillance solutions market is driven by several factors, including increasing healthcare-associated infection rates, technological advancements, and stringent regulatory requirements. The rising prevalence of chronic diseases and subsequent increase in hospital stays have also escalated the risk of healthcare-associated infections, thereby boosting the demand for effective surveillance systems. Technological innovations, such as integration with electronic health records and real-time analytics, have enhanced the efficiency and efficacy of these systems. Additionally, the growing global emphasis on healthcare quality and patient safety, supported by government initiatives and funding for health infrastructure, has propelled the adoption of advanced surveillance solutions

Scope of the Study

The report analyzes the Infection Surveillance Solutions market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Type (Software, Services); End-Use (Hospitals, Long-Term Care Facilities, Other End-Uses).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Infection Surveillance Software segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 15.6%. The Infection Surveillance Services segment is also set to grow at 17.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $278.7 Million in 2024, and China, forecasted to grow at an impressive 17.3% CAGR to reach $233.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as IBM Corporation, Becton, Dickinson and Company, bioMerieux SA, Illumina, Inc., Cerner Corporation and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Infection Surveillance Solutions Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infection Surveillance Solutions Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Infection Surveillance Solutions Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 40 major companies featured in this Infection Surveillance Solutions market report include:

  • IBM Corporation
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Illumina, Inc.
  • Cerner Corporation
  • Ecolab, Inc.
  • Gojo Industries, Inc.
  • Epic Systems Corporation
  • CenTrak, Inc.
  • Iatric Systems, Inc.
  • Harris Healthcare
  • Perahealth, Inc.
  • ABILITY Network Inc.
  • Asolva, Inc.
  • ICNet International

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • A Prelude to Infection Surveillance Solutions
  • Global Economic Update
  • Infection Surveillance Solutions - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Market Analysis and Prospects
  • Infection Surveillance Solutions Market Witnesses Steady Growth
  • Surveillance Software Holds a Significant Share
  • By Infection Type, UTI Holds a Strong Place
  • Hospitals Account for a Major Share of the Market
  • North America and Europe Hold Major Presence, Asia-Pacific to Witness Fastest Growth
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Prevalence of Infectious Diseases Spurs Demand for Infection Surveillance Solutions
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Rising Incidence of Hospital Acquired Infections (HAIs) Drives Market Growth
  • Mitigating the Risks Associated With Hospital-Acquired Infections
  • Shift to proactive From Reactive
  • Initiatives for Stewardship
  • Report Production
  • Government Measures to Control HAIs Drive Infection Surveillance Solutions Market
  • Rising Prevalence of Respiratory Infections to Drive Need for POC Molecular Diagnostics
  • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
  • Infection Control Software Witnesses Steady Growth
  • Advantages of Infection Control Software
  • Clinical Surveillance Innovation to Spur the Infection Surveillance Solutions Market
  • Rising Need to Reduce Healthcare Costs to Propel Demand for Infection Surveillance Solutions
  • Current & Required Healthcare Spending as % of GDP
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Rapidly Aging World Population to Drive Demand
  • Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Digitalization of Healthcare and Technological Advancements
  • Increasing Complexity of Healthcare Operations to Spur Demand for Infection Surveillance Solutions Market
  • The Move to Cloud Gains Momentum
  • Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Market Opportunities
  • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Long-Term Care Facilities by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 19: World Infection Surveillance Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Active Players in United States
  • TABLE 20: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: USA 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: USA 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
  • Active Players in Canada
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: Canada 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: Canada 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Active Players in Japan
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: Japan 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Japan 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Active Players in China
  • TABLE 38: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: China 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: China 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Europe 15-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Europe 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Europe 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Active Players in France
  • TABLE 53: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: France 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: France 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Active Players in Germany
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Germany 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Germany 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
  • Active Players in Italy
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Italy 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Italy 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Active Players in United Kingdom
  • TABLE 71: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: UK 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: UK 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Active Players in Rest of Europe
  • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Rest of Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Rest of Europe 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Rest of Europe 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Active Players in Asia-Pacific
  • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Asia-Pacific Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Asia-Pacific 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Asia-Pacific 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
REST OF WORLD
  • Active Players in Rest of World
  • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Rest of World Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Rest of World 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2015, 2025 & 2030
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of World 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2015, 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • IBM Corporation
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Illumina, Inc.
  • Cerner Corporation
  • Ecolab, Inc.
  • Gojo Industries, Inc.
  • Epic Systems Corporation
  • CenTrak, Inc.
  • Iatric Systems, Inc.
  • Harris Healthcare
  • Perahealth, Inc.
  • ABILITY Network Inc.
  • Asolva, Inc.
  • ICNet International

Table Information